Cure My Disease

Don't miss your cure!

 Log in / Sign up

The effects of positive birth experience sharing and guided imagery on childbirth Self-Efficacy and fear of childbirth

NCT ID NCT07015086

NEW Sponsor: Gazi University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 09, 2026 · Last updated Sep 09, 2026

Summary

Brief Summary This randomized controlled trial evaluates the effects of positive birth experience sharing combined with guided imagery on fear of childbirth and childbirth self-efficacy in primiparous pregnant women. The study is a single-center, two-arm, parallel-group randomized controlled trial using stratified block randomization based on baseline fear of childbirth. A total of 62 pregnant women were randomized in a 1:1 ratio to the intervention group (n=31) or control group (n=31). Participants were enrolled at 26-28 weeks of gestation. Before randomization, participants completed the Personal Information Form, the Wijma Delivery Expectancy/Experience Questionnaire Version A (W-DEQ-A), and the Childbirth Self-Efficacy Inventory-Short Form (CBSEI-C32) online. Participants were stratified according to their baseline W-DEQ-A scores and then randomly allocated to the intervention or control group. The intervention was delivered individually and online via WhatsApp. Women in the intervention group participated in an approximately 30-minute individual online session during which one of the researchers shared a positive personal birth experience and answered participants' questions about childbirth. Participants were also provided with a standardized Turkish guided imagery audio recording based on childbirth-focused guided imagery techniques. They were instructed to listen to the approximately 20-minute recording independently once or twice daily for 10 weeks, preferably before bedtime. Daily WhatsApp reminders and a guided imagery exercise follow-up chart were used to support and monitor adherence. Women in the control group received routine antenatal care and did not receive the positive birth experience sharing or guided imagery intervention. At the end of the 10-week intervention period, participants in both groups completed the W-DEQ-A and CBSEI-C32 online. Within the first three days after childbirth, the W-DEQ-B was administered online and mode of birth was recorded.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 62 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2025

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Aged 18 years or older Primiparous At 26-28 weeks of gestation at enrollment No maternal or fetal complications during the current pregnancy (e.g., gestational diabetes, hypertension, preeclampsia, intrauterine growth restriction, or congenital anomalies) No mental, hearing, visual, language, or other communication problems that could interfere with participation Able to use WhatsApp® and access the online study procedures Willing to participate in the study and provide informed consent Exclusion Criteria: Development of a maternal or fetal complication during the study Birth before 37 weeks of gestation Withdrawal from the study at the participant's request Failure to complete the post-intervention assessment Failure to perform the guided imagery exercise for three consecutive days (intervention group only)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Childbirth are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Childbirth

Contacts and locations

Locations

  • Nursing Faculty of Gazi University

    Ankara, Turkey, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.